{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["aptasensor", "cancer", "electrochemical transduction", "genosensor", "pathogen detection", "quantum dots"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37222166", "DateRevised": {"Year": "2023", "Month": "10", "Day": "24"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "05", "Day": "24"}], "Language": ["eng"], "ELocationID": ["10.1002/btpr.3366"], "Journal": {"ISSN": "1520-6033", "JournalIssue": {"Volume": "39", "Issue": "5", "PubDate": {"Year": "2023", "Season": "Sep-Oct"}}, "Title": "Biotechnology progress", "ISOAbbreviation": "Biotechnol Prog"}, "ArticleTitle": "Aptamer-functionalized quantum dots as theranostic nanotools against cancer and bacterial infections: A comprehensive overview of recent trends.", "Pagination": {"StartPage": "e3366", "MedlinePgn": "e3366"}, "Abstract": {"AbstractText": ["Aptamers (Apts) are synthetic nucleic acid ligands that can be engineered to target various molecules, including amino acids, proteins, and pharmaceuticals. Through a series of adsorption, recovery, and amplification steps, Apts are extracted from combinatorial libraries of synthesized nucleic acids. Using aptasensors in bioanalysis and biomedicine can be improved by combining them with nanomaterials. Moreover, Apt-associated nanomaterials, including liposomes, polymeric, dendrimers, carbon nanomaterials, silica, nanorods, magnetic NPs, and quantum dots (QDs), have been widely used as promising nanotools in biomedicine. Following surface modifications and conjugation with appropriate functional groups, these nanomaterials can be successfully used in aptasensing. Advanced biological assays can use Apts immobilized on QD surfaces through physical interaction and chemical bonding. Accordingly, modern QD aptasensing platforms rely on interactions between QDs, Apts, and targets to detect them. QD-Apt conjugates can be used to directly detect prostate, ovarian, colorectal, and lung cancers or simultaneously detect biomarkers associated with these malignancies. Tenascin-C, mucin 1, prostate-specific antigen, prostate-specific membrane antigen, nucleolin, growth factors, and exosomes are among the cancer biomarkers that can be sensitively detected using such bioconjugates. Furthermore, Apt-conjugated QDs have shown great potential for controlling bacterial infections such as Bacillus thuringiensis, Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii, Campylobacter jejuni, Staphylococcus aureus, and Salmonella typhimurium. This comprehensive review discusses recent advancements in the design of QD-Apt bioconjugates and their applications in cancer and bacterial theranostics."], "CopyrightInformation": "\u00a9 2023 The Authors. Biotechnology Progress published by Wiley Periodicals LLC on behalf of American Institute of Chemical Engineers."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Faculty of Basic Science, Payame Noor University, Tehran, Iran."}], "LastName": "Davodabadi", "ForeName": "Fatemeh", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cellular and Molecular Research Center, Research Institute of Cellular and Molecular Sciences in Infectious Diseases, Zahedan University of Medical Sciences, Zahedan, Iran."}], "LastName": "Mirinejad", "ForeName": "Shekoufeh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Advanced Sciences and Technologies in Medicine, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran."}, {"Identifier": [], "Affiliation": "Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Fathi-Karkan", "ForeName": "Sonia", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cellular and Molecular Research Center, Research Institute of Cellular and Molecular Sciences in Infectious Diseases, Zahedan University of Medical Sciences, Zahedan, Iran."}], "LastName": "Majidpour", "ForeName": "Mahdi", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Engineering, Faculty of Engineering, University of Tehran, Tehran, Iran."}], "LastName": "Ajalli", "ForeName": "Narges", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacology Research Center, Zahedan University of Medical Sciences, Zahedan, Iran."}], "LastName": "Sheervalilou", "ForeName": "Roghayeh", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cellular and Molecular Research Center, Research Institute of Cellular and Molecular Sciences in Infectious Diseases, Zahedan University of Medical Sciences, Zahedan, Iran."}], "LastName": "Sargazi", "ForeName": "Saman", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Faculty of Biology and Biotechnology, University of Warmia and Mazury, Olsztyn, Poland."}], "LastName": "Rozmus", "ForeName": "Dominika", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physics, University of Zabol, Zabol, Iran."}], "LastName": "Rahdar", "ForeName": "Abbas", "Initials": "A"}, {"Identifier": ["0000-0001-7405-2354"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Universidad de Alcal\u00e1, Facultad de Ciencias, Departamento de Quimica Analitica, Quimica Fisica e Ingenieria Quimica, Madrid, Spain."}], "LastName": "Diez-Pascual", "ForeName": "Ana M", "Initials": "AM"}], "GrantList": [{"GrantID": "EPU-INV/2020/012", "Agency": "Community of Madrid within the framework of the Multiyear Agreement with the University of Alcal\u00e1 in the line of action \"Stimulus to Excellence for Permanent University Professors\"", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Biotechnol Prog", "NlmUniqueID": "8506292", "ISSNLinking": "1520-6033"}}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ni B, Fu C, Pan S, He L, Lin Z, Peng J. Semiconducting Spaghetti-like Organic-Inorganic Nanojunctions via Sequential Self-Assembly of Conjugated Polymers and Quantum Dots. Chem Mater. 2022;34:847-853."}, {"Citation": "Borghei Y-S, Hosseinkhani S. \u201cSemiconductor quantum dots\u201d in biomedical opportunities. J Lumin. 2022;243:118626."}, {"Citation": "Ghaffarkhah A, Hosseini E, Kamkar M, et al. Synthesis, applications, and prospects of graphene quantum dots: a comprehensive review. Small. 2022;18(2):2102683."}, {"Citation": "Ikram A, Zulfequar M, Satsangi VR. Role and prospects of green quantum dots in photoelectrochemical hydrogen generation: a review. Int J Hydrog Energy. 2022;47:11472-11491."}, {"Citation": "Boakye-Yiadom KO, Kesse S, Opoku-Damoah Y, et al. Carbon dots: applications in bioimaging and theranostics. Int J Pharm. 2019;564:308-317."}, {"Citation": "Kulkarni NS, Guererro Y, Gupta N, Muth A, Gupta V. Exploring potential of quantum dots as dual modality for cancer therapy and diagnosis. J Drug Deliv Sci Technol. 2019;49:352-364."}, {"Citation": "Mitchell P. Turning the spotlight on cellular imaging. Nat Biotechnol. 2001;19(11):1013-1017."}, {"Citation": "Mattoussi H, Mauro JM, Goldman ER, et al. Self-assembly of CdSe\u2212 ZnS quantum dot bioconjugates using an engineered recombinant protein. J Am Chem Soc. 2000;122(49):12142-12150."}, {"Citation": "Bruchez M Jr, Moronne M, Gin P, Weiss S, Alivisatos AP. Semiconductor nanocrystals as fluorescent biological labels. Science. 1998;281(5385):2013-2016."}, {"Citation": "Hermanson GT. Bioconjugate techniques. Academic press; 2013."}, {"Citation": "Mohammadi R, Naderi-Manesh H, Farzin L, et al. Fluorescence sensing and imaging with carbon-based quantum dots for early diagnosis of cancer: a review. J Pharm Biomed Anal. 2022;114628:114628."}, {"Citation": "Das M, Duan W, Sahoo SK. Multifunctional nanoparticle-EpCAM aptamer bioconjugates: a paradigm for targeted drug delivery and imaging in cancer therapy. Nanomed Nanotechnol Biol Med. 2015;11(2):379-389."}, {"Citation": "Mandal TK, Parvin N. Rapid detection of bacteria by carbon quantum dots. J Biomed Nanotechnol. 2011;7(6):846-848."}, {"Citation": "Hahn MA, Tabb JS, Krauss TD. Detection of single bacterial pathogens with semiconductor quantum dots. Anal Chem. 2005;77(15):4861-4869."}, {"Citation": "Nasrollahi F, Koh YR, Chen P, Varshosaz J, Khodadadi AA, Lim S. Targeting graphene quantum dots to epidermal growth factor receptor for delivery of cisplatin and cellular imaging. Mater Sci Eng C. 2019;94:247-257."}, {"Citation": "Ghafary SM, Rahimjazi E, Hamzehil H, Mousavi SMM, Nikkhah M, Hosseinkhani S. Design and preparation of a theranostic peptideticle for targeted cancer therapy: peptide-based codelivery of doxorubicin/curcumin and graphene quantum dots. Nanomedicine. 2022;42:102544."}, {"Citation": "Ruzycka-Ayoush M, Kowalik P, Kowalczyk A, et al. Quantum dots as targeted doxorubicin drug delivery nanosystems in human lung cancer cells. Cancer Nanotechnol. 2021;12:1-27."}, {"Citation": "Xiong L, Xia M, Wang Q, et al. DNA Aptamers Specific for Legionella Pneumophila: Systematic Evolution of Ligands by Exponential Enrichment in Whole Bacterial Cells. 2022."}, {"Citation": "Zhang H, Zhou L, Zhu Z, Yang C. Recent progress in aptamer-based functional probes for bioanalysis and biomedicine. Chem Eur J. 2016;22(29):9886-9900."}, {"Citation": "Ni X, Castanares M, Mukherjee A, Lupold SE. Nucleic acid aptamers: clinical applications and promising new horizons. Curr Med Chem. 2011;18(27):4206-4214."}, {"Citation": "Sun H, Zhu X, Lu PY, Rosato RR, Tan W, Zu Y. Oligonucleotide aptamers: new tools for targeted cancer therapy. Mol Ther Nucleic Acids. 2014;3:e182."}, {"Citation": "Majdinasab M, Hayat A, Marty JL. Aptamer-based assays and aptasensors for detection of pathogenic bacteria in food samples. TrAC Trends Anal Chem. 2018;107:60-77."}, {"Citation": "Foubert A, Beloglazova NV, Rajkovic A, et al. Bioconjugation of quantum dots: review & impact on future application. TrAC Trends Anal Chem. 2016;83:31-48."}, {"Citation": "Savla R, Taratula O, Garbuzenko O, Minko T. Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer. J Control Release. 2011;153(1):16-22."}, {"Citation": "Li J, Xu M, Huang H, et al. Aptamer-quantum dots conjugates-based ultrasensitive competitive electrochemical cytosensor for the detection of tumor cell. Talanta. 2011;85(4):2113-2120."}, {"Citation": "Zhou J, Rossi J. Aptamers as targeted therapeutics: current potential and challenges. Nat Rev Drug Discov. 2017;16(3):181-202."}, {"Citation": "Li H-Y, Jia W-N, Li X-Y, Zhang L, Liu C, Wu J. Advances in detection of infectious agents by aptamer-based technologies. Emerg Microb Infect. 2020;9(1):1671-1681."}, {"Citation": "Samimi E, Karami P, Ahar MJ. A review on aptamer-conjugated quantum dot nanosystems for cancer imaging and theranostic. J Nanomed Res. 2017;5:117."}, {"Citation": "Wen L, Qiu L, Wu Y, Hu X, Zhang X. Aptamer-modified semiconductor quantum dots for biosensing applications. Sensors. 2017;17(8):1736."}, {"Citation": "Kim D, Yoo S. Aptamer-conjugated quantum dot optical biosensors: strategies and applications. Chem. 2021;9(11):318."}, {"Citation": "Alshehri S, Imam SS, Rizwanullah M, et al. Progress of cancer nanotechnology as diagnostics, therapeutics, and theranostics nanomedicine: preclinical promise and translational challenges. Pharmaceutics. 2020;13, (1):24."}, {"Citation": "Haider N, Fatima S, Taha M, et al. Nanomedicines in diagnosis and treatment of cancer: an update. Curr Pharm Des. 2020;26(11):1216-1231."}, {"Citation": "Nehilla BJ, Allen PG, Desai TA. Surfactant-free, drug-quantum-dot coloaded poly (lactide-co-glycolide) nanoparticles: towards multifunctional nanoparticles. ACS Nano. 2008;2(3):538-544."}, {"Citation": "Pan J, Feng S-S. Targeting and imaging cancer cells by folate-decorated, quantum dots (QDs)-loaded nanoparticles of biodegradable polymers. Biomaterials. 2009;30(6):1176-1183."}, {"Citation": "Zhang L, Radovic-Moreno AF, Alexis F, et al. Co-delivery of hydrophobic and hydrophilic drugs from nanoparticle-aptamer bioconjugates. ChemMedChem: Chem Enab Drug Discov. 2007;2(9):1268-1271."}, {"Citation": "Bagalkot V, Farokhzad OC, Langer R, Jon S. An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform. Angew Chem Int Ed. 2006;45(48):8149-8152."}, {"Citation": "Zhang H. Quantum dot-A10 RNA aptamer-doxorubicin conjugate. 2010."}, {"Citation": "Bagalkot V, Zhang L, Levy-Nissenbaum E, et al. Quantum dot\u2212 aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer. Nano Lett. 2007;7(10):3065-3070."}, {"Citation": "Sarkar N, Sahoo G, Das R, Prusty G, Swain SK. Carbon quantum dot tailored calcium alginate hydrogel for pH responsive controlled delivery of vancomycin. Eur J Pharm Sci. 2017;109:359-371."}, {"Citation": "Gui R, Wan A, Jin H. Retracted Article: facile synthesis of quantum dots/mesoporous silica/quantum dots core/shell/shell hybrid microspheres for ratiometric fluorescence detection of 5-fluorouracil in human serum. Analyst. 2013;138(20):5956-5964."}, {"Citation": "Jain RK. Transport of molecules, particles, and cells in solid tumors. Annu Rev Biomed Eng. 1999;1(1):241-263."}, {"Citation": "Jain RK. Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function. J Control Release. 2001;74(1-3):7-25."}, {"Citation": "Lanza GM, Wallace KD, Fischer SE, et al. High-frequency ultrasonic detection of thrombi with a targeted contrast system. Ultrasound Med Biol. 1997;23(6):863-870."}, {"Citation": "Wang X, Yang L, Chen Z, Shin DM. Application of nanotechnology in cancer therapy and imaging. CA Cancer J Clin. 2008;58(2):97-110."}, {"Citation": "Gao X, Yang L, Petros JA, Marshall FF, Simons JW, Nie S. In vivo molecular and cellular imaging with quantum dots. Curr Opin Biotechnol. 2005;16(1):63-72."}, {"Citation": "Manabe N, Hoshino A, Liang Y-Q, Goto T, Kato N, Yamamoto K. Quantum dot as a drug tracer in vivo. IEEE Trans Nanobioscience. 2006;5(4):263-267."}, {"Citation": "Samia AC, Chen X, Burda C. Semiconductor quantum dots for photodynamic therapy. J Am Chem Soc. 2003;125(51):15736-15737."}, {"Citation": "Bakalova R, Ohba H, Zhelev Z, Ishikawa M, Baba Y. Quantum dots as photosensitizers? Nat Biotechnol. 2004;22(11):1360-1361."}, {"Citation": "Azzazy HM, Mansour MM, Kazmierczak SC. From diagnostics to therapy: prospects of quantum dots. Clin Biochem. 2007;40(13-14):917-927."}, {"Citation": "Kaur H. Aptamer conjugated quantum dots for imaging cellular uptake in cancer cells. J Nanosci Nanotechnol. 2019;19(7):3798-3803."}, {"Citation": "Chan W, Nie S. Quantum dots for ultrasensitive biological detection. Science. 1998;281:2016-2018."}, {"Citation": "Wu X, Liu H, Liu J, et al. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat Biotechnol. 2003;21:41-46."}, {"Citation": "Yong K-T, Ding H, Roy I, et al. Imaging pancreatic cancer using bioconjugated InP quantum dots. ACS Nano. 2009;3(3):502-510."}, {"Citation": "Liu W, Howarth M, Greytak AB, et al. Compact biocompatible quantum dots functionalized for cellular imaging. J Am Chem Soc. 2008;130(4):1274-1284."}, {"Citation": "Wu L, Qu X. Cancer biomarker detection: recent achievements and challenges. Chem Soc Rev. 2015;44(10):2963-2997."}, {"Citation": "Wang F-B, Rong Y, Fang M, et al. Recognition and capture of metastatic hepatocellular carcinoma cells using aptamer-conjugated quantum dots and magnetic particles. Biomaterials. 2013;34(15):3816-3827."}, {"Citation": "Wang K, Fan D, Liu Y, Wang E. Highly sensitive and specific colorimetric detection of cancer cells via dual-aptamer target binding strategy. Biosens Bioelectron. 2015;73:1-6."}, {"Citation": "Liu H, Xu S, He Z, Deng A, Zhu J-J. Supersandwich cytosensor for selective and ultrasensitive detection of cancer cells using aptamer-DNA concatamer-quantum dots probes. Anal Chem. 2013;85(6):3385-3392."}, {"Citation": "Pan C, Guo M, Nie Z, Xiao X, Yao S. Aptamer-based electrochemical sensor for label-free recognition and detection of cancer cells. Electroanal Int J Devot Fund Pract Aspect Electroanal. 2009;21(11):1321-1326."}, {"Citation": "Pan Y, Guo M, Nie Z, et al. Selective collection and detection of leukemia cells on a magnet-quartz crystal microbalance system using aptamer-conjugated magnetic beads. Biosens Bioelectron. 2010;25(7):1609-1614."}, {"Citation": "Yu Y, Duan S, He J, et al. Highly sensitive detection of leukemia cells based on aptamer and quantum dots. Oncol Rep. 2016;36(2):886-892."}, {"Citation": "Wu C, Liu J, Zhang P, et al. A recognition-before-labeling strategy for sensitive detection of lung cancer cells with a quantum dot-aptamer complex. Analyst. 2015;140(17):6100-6107."}, {"Citation": "Miao W, Kim H, Gujrati V, et al. Photo-decomposable organic nanoparticles for combined tumor optical imaging and multiple phototherapies. Theranostics. 2016;6(13):2367-2379."}, {"Citation": "Cao Y, Dong H, Yang Z, et al. Aptamer-conjugated graphene quantum dots/porphyrin derivative theranostic agent for intracellular cancer-related microRNA detection and fluorescence-guided photothermal/photodynamic synergetic therapy. ACS Appl Mater Interfaces. 2017;9(1):159-166."}, {"Citation": "Ruiz Ciancio D, Vargas MR, Thiel WH, Bruno MA, Giangrande PH, Mestre MB. Aptamers as diagnostic tools in cancer. Pharmaceuticals. 2018;11(3):86."}, {"Citation": "Li W-M, Bing T, Wei J-Y, Chen Z-Z, Shangguan D-H, Fang J. Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells. Biomaterials. 2014;35(25):6998-7007."}, {"Citation": "Otoshi T, Nagano T, Tachihara M, Nishimura Y. Possible biomarkers for cancer immunotherapy. Cancers. 2019;11(7):935."}, {"Citation": "Kumar S, Mohan A, Guleria R. Biomarkers in cancer screening, research and detection: present and future: a review. Biomarkers. 2006;11(5):385-405."}, {"Citation": "Srinivas PR, Kramer BS, Srivastava S. Trends in biomarker research for cancer detection. Lancet Oncol. 2001;2(11):698-704."}, {"Citation": "Yalcin F, Dzaye O, Xia S. Tenascin-C function in glioma: immunomodulation and beyond. Tumor Microenviron Extracell Matrix Comp-Part B. 2020;1272:149-172."}, {"Citation": "Mishra P, Kiebish MA, Cullen J, et al. Genomic alterations of Tenascin C in highly aggressive prostate cancer: a meta-analysis. Genes Cancer. 2019;10(5-6):150."}, {"Citation": "Lowy CM, Oskarsson T. Tenascin C in metastasis: a view from the invasive front. Cell Adhes Migr. 2015;9(1-2):112-124."}, {"Citation": "Qi J, Esfahani D, Huang T, et al. Tenascin-C expression contributes to pediatric brainstem glioma tumor phenotype and represents a novel biomarker of disease. Acta Neuropathol Commun. 2019;7:1-19."}, {"Citation": "Chen X-C, Deng Y-L, Lin Y, et al. Quantum dot-labeled aptamer nanoprobes specifically targeting glioma cells. Nanotechnology. 2008;19(23):235105."}, {"Citation": "Li Z, Huang P, He R, et al. Aptamer-conjugated dendrimer-modified quantum dots for cancer cell targeting and imaging. Mater Lett. 2010;64(3):375-378."}, {"Citation": "Chen W, Zhang Z, Zhang S, Zhu P, Ko JK-S, Yung KK-L. MUC1: structure, function, and clinic application in epithelial cancers. Int J Mol Sci. 2021;22(12):6567."}, {"Citation": "Qing L, Li Q, Yang Y, Xu W, Dong Z. A prognosis marker MUC1 correlates with metabolism and drug resistance in bladder cancer: a bioinformatics research. BMC Urol. 2022;22(1):114."}, {"Citation": "Jing X, Liang H, Hao C, Yang X, Cui X. Overexpression of MUC1 predicts poor prognosis in patients with breast cancer. Oncol Rep. 2019;41(2):801-810."}, {"Citation": "Li W, Zhang N, Jin C, et al. MUC1-C drives stemness in progression of colitis to colorectal cancer. JCI Insight. 2020;5:12."}, {"Citation": "Li C, Liu T, Yin L, Zuo D, Lin Y, Wang L. Prognostic and clinicopathological value of MUC1 expression in colorectal cancer: a meta-analysis. Medicine. 2019;98:9."}, {"Citation": "Kim Y-I, Pecha RL, Keihanian T, et al. MUC1 Expressions and Its Prognostic Values in US Gastric Cancer Patients. Cancer. 2023;15(4):998."}, {"Citation": "Yang J. Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer. Med Oncol. 2020;37(5):34."}, {"Citation": "Lakshmanan I, Ponnusamy MP, Macha MA, et al. Mucins in lung cancer: diagnostic, prognostic, and therapeutic implications. J Thorac Oncol. 2015;10(1):19-27."}, {"Citation": "Jain S, Nadeem N, Ulfenborg B, et al. Diagnostic potential of nanoparticle aided assays for MUC16 and MUC1 glycovariants in ovarian cancer. Int J Cancer. 2022;151(7):1175-1184."}, {"Citation": "Ma Q, Song J, Wang S, He N. MUC1 regulates AKT signaling pathway by upregulating EGFR expression in ovarian cancer cells. Patho Res Pract. 2021;224:153509."}, {"Citation": "Yasumizu Y, Rajabi H, Jin C, et al. MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer. Nat Commun. 2020;11(1):338."}, {"Citation": "Bose M, Sanders A, De C, et al. Targeting tumor-associated MUC1 overcomes anoikis-resistance in pancreatic cancer. Transl Res. 2023;253:41-56."}, {"Citation": "Cheng AK, Su H, Wang YA, Yu H-Z. Aptamer-based detection of epithelial tumor marker mucin 1 with quantum dot-based fluorescence readout. Anal Chem. 2009;81(15):6130-6139."}, {"Citation": "Shin S, Nam HY, Lee EJ, Jung W, Hah SS. Molecular beacon-based quantitiation of epithelial tumor marker mucin 1. Bioorg Med Chem Lett. 2012;22(19):6081-6084."}, {"Citation": "Zhang C, Ji X, Zhang Y, et al. One-pot synthesized aptamer-functionalized CdTe: Zn2+ quantum dots for tumor-targeted fluorescence imaging in vitro and in vivo. Anal Chem. 2013;85(12):5843-5849."}, {"Citation": "Lin Z, Ma Q, Fei X, Zhang H, Su X. A novel aptamer functionalized CuInS2 quantum dots probe for daunorubicin sensing and near infrared imaging of prostate cancer cells. Anal Chim Acta. 2014;818:54-60."}, {"Citation": "Ranjbar-Navazi Z, Fathi M, Abdolahinia ED, Omidi Y, Davaran S. MUC-1 aptamer conjugated InP/ZnS quantum dots/nanohydrogel fluorescent composite for mitochondria-mediated apoptosis in MCF-7 cells. Mater Sci Eng C. 2021;118:111469."}, {"Citation": "Singh S, Jha P, Singh V, et al. A quantum dot-MUC1 aptamer conjugate for targeted delivery of protoporphyrin IX and specific photokilling of cancer cells through ROS generation. Integr Biol. 2016;8(10):1040-1048."}, {"Citation": "Ablin RJ. The great prostate mistake. New York Times. 2010;360:1310-1319."}, {"Citation": "Heidenreich A, Bastian PJ, Bellmunt J, et al. EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol. 2014;65(2):467-479."}, {"Citation": "Wu G, Datar RH, Hansen KM, Thundat T, Cote RJ, Majumdar A. Bioassay of prostate-specific antigen (PSA) using microcantilevers. Nat Biotechnol. 2001;19(9):856-860."}, {"Citation": "Arneth BM. Clinical significance of measuring prostate-specific antigen. Lab Med. 2009;40(8):487-491."}, {"Citation": "Hirachand S, Dangol U, Pradhanang S, Acharya S. Study of prostatic pathology and its correlation with prostate specific antigen level. J Pathol Nepal. 2017;7(1):1074-1077."}, {"Citation": "Altekruse S. SEER cancer statistics review, 1975-2007. 2009 http://seer.cancer.gov/csr/1975_2007/results_merged/sect_13_leukemia.pdf"}, {"Citation": "Abbasy L, Mohammadzadeh A, Hasanzadeh M, Razmi N. Development of a reliable bioanalytical method based on prostate specific antigen trapping on the cavity of molecular imprinted polymer towards sensing of PSA using binding affinity of PSA-MIP receptor: a novel biosensor. J Pharm Biomed Anal. 2020;188:113447."}, {"Citation": "Farshchi F, Hasanzadeh M. Nanomaterial based aptasensing of prostate specific antigen (PSA): recent progress and challenges in efficient diagnosis of prostate cancer using biomedicine. Biomed Pharmacother. 2020;132:110878."}, {"Citation": "Kavosi B, Navaee A, Salimi A. Amplified fluorescence resonance energy transfer sensing of prostate specific antigen based on aggregation of CdTe QDs/antibody and aptamer decorated of AuNPs-PAMAM dendrimer. J Lumin. 2018;204:368-374."}, {"Citation": "Fang B-Y, Wang C-Y, Li C, Wang H-B, Zhao Y-D. Amplified using DNase I and aptamer/graphene oxide for sensing prostate specific antigen in human serum. Sensors Actuators B Chem. 2017;244:928-933."}, {"Citation": "Nxele SR, Nyokong T. The effects of the composition and structure of quantum dots combined with cobalt phthalocyanine and an aptamer on the electrochemical detection of prostate specific antigen. Dyes Pigments. 2021;192:109407."}, {"Citation": "Wang S-F, Chen T, Zhang Z-L, et al. Direct electrochemistry and electrocatalysis of heme proteins entrapped in agarose hydrogel films in room-temperature ionic liquids. Langmuir. 2005;21(20):9260-9266."}, {"Citation": "Al-Ahmadie HA, Olgac S, Gregor PD, et al. Expression of prostate-specific membrane antigen in renal cortical tumors. Mod Pathol. 2008;21(6):727-732."}, {"Citation": "Farag M, Bolton D, Lawrentschuk N. Prostate-specific membrane antigen for the surgical oncologist: interpreting expression beyond the prostate. ANZ J Surg. 2020;90(5):715-718."}, {"Citation": "Wang F, Li Z, Feng X, Yang D, Lin M. Advances in PSMA-targeted therapy for prostate cancer. Prostate Cancer Prostatic Dis. 2022;25(1):11-26."}, {"Citation": "Derks YH, Rijpkema M, Amatdjais-Groenen HI, et al. Photosensitizer-based multimodal PSMA-targeting ligands for intraoperative detection of prostate cancer. Photosensitizer-based multimodal PSMA-targeting ligands for intraoperative detection of prostate cancer. Theranostics;\u00a02021."}, {"Citation": "Ceci F, Fanti S. PSMA-PET/CT imaging in prostate cancer: why and when. Clin Transl Imaging. 2019;7:377-379."}, {"Citation": "Banerjee SR, Foss CA, Castanares M, et al. Synthesis and evaluation of technetium-99m-and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA). J Med Chem. 2008;51(15):4504-4517."}, {"Citation": "Bao K, Lee JH, Kang H, Park GK, El Fakhri G, Choi HS. PSMA-targeted contrast agents for intraoperative imaging of prostate cancer. Chem Commun. 2017;53(10):1611-1614."}, {"Citation": "Huang SS, Wang X, Zhang Y, Doke A, DiFilippo FP, Heston WD. Improving the biodistribution of PSMA-targeting tracers with a highly negatively charged linker. Prostate. 2014;74(7):702-713."}, {"Citation": "Shieh F, Lavery L, Chu CT, Richards-Kortum R, Ellington AD, Korgel BA. In Semiconductor nanocrystal-aptamer bioconjugate probes for specific prostate carcinoma cell targeting, Nanobiophotonics and Biomedical Applications II, 2005; SPIE: 2005; pp. 159-165."}, {"Citation": "Chu TC, Shieh F, Lavery LA, et al. Labeling tumor cells with fluorescent nanocrystal-aptamer bioconjugates. Biosens Bioelectron. 2006;21(10):1859-1866."}, {"Citation": "Berger CM, Gaume X, Bouvet P. The roles of nucleolin subcellular localization in cancer. Biochimie. 2015;113:78-85."}, {"Citation": "Chen Z, Xu X. Roles of nucleolin: focus on cancer and anti-cancer therapy. Saudi Med J. 2016;37(12):1312-1318."}, {"Citation": "Hammoudi A, Song F, Reed KR, et al. Proteomic profiling of a mouse model of acute intestinal Apc deletion leads to identification of potential novel biomarkers of human colorectal cancer (CRC). Biochem Biophys Res Commun. 2013;440(3):364-370."}, {"Citation": "Qiu W, Zhou F, Zhang Q, et al. Overexpression of nucleolin and different expression sites both related to the prognosis of gastric cancer. APMIS. 2013;121(10):919-925."}, {"Citation": "Zhao H, Huang Y, Xue C, et al. Prognostic significance of the combined score of endothelial expression of nucleolin and CD31 in surgically resected non-small cell lung cancer. PLoS One. 2013;8(1):e54674."}, {"Citation": "Lian S, Zhang P, Gong P, et al. A universal quantum dots-aptamer probe for efficient cancer detection and targeted imaging. J Nanosci Nanotechnol. 2012;12(10):7703-7708."}, {"Citation": "Alibolandi M, Abnous K, Ramezani M, Hosseinkhani H, Hadizadeh F. Synthesis of AS1411-aptamer-conjugated CdTe quantum dots with high fluorescence strength for probe labeling tumor cells. J Fluoresc. 2014;24(5):1519-1529."}, {"Citation": "Normanno N, De Luca A, Bianco C, et al. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene. 2006;366(1):2-16."}, {"Citation": "Baselga J. Why the epidermal growth factor receptor? The rationale for cancer therapy. Oncologist. 2002;7(S4):2-8."}, {"Citation": "Roskoski R Jr. The ErbB/HER family of protein-tyrosine kinases and cancer. Pharmacol Res. 2014;79:34-74."}, {"Citation": "Maennling AE, Tur MK, Niebert M, et al. Molecular targeting therapy against EGFR family in breast cancer: progress and future potentials. Cancer. 2019;11(12):1826."}, {"Citation": "Cohen RB. Epidermal growth factor receptor as a therapeutic target in colorectal cancer. Clin Colorectal Cancer. 2003;2(4):246-251."}, {"Citation": "Chen I, Chang J, Liao C, Wang H, Hsieh L, Cheng A. Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area. Br J Cancer. 2003;89(4):681-686."}, {"Citation": "Thariat J, Etienne-Grimaldi M-C, Grall D, et al. Epidermal growth factor receptor protein detection in head and neck cancer patients: a many-faceted picture assessing EGFR expression in head and neck tumors. Clin Cancer Res. 2012;18(5):1313-1322."}, {"Citation": "Vasudev A, Kaushik A, Bhansali S. Electrochemical immunosensor for label free epidermal growth factor receptor (EGFR) detection. Biosens Bioelectron. 2013;39(1):300-305."}, {"Citation": "Kim MW, Jeong HY, Kang SJ, et al. Anti-EGF receptor aptamer-guided co-delivery of anti-cancer siRNAs and quantum dots for theranostics of triple-negative breast cancer. Theranostics. 2019;9(3):837-852."}, {"Citation": "Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013;155(2):462-477."}, {"Citation": "Liu Z, Han L, Dong Y, et al. EGFRvIII/integrin \u03b23 interaction in hypoxic and vitronectinenriching microenvironment promote GBM progression and metastasis. Oncotarget. 2016;7(4):4680-4694."}, {"Citation": "Yin J, Park G, Kim TH, et al. Pigment epithelium-derived factor (PEDF) expression induced by EGFRvIII promotes self-renewal and tumor progression of glioma stem cells. PLoS Biol. 2015;13(5):e1002152."}, {"Citation": "Lammering G, Hewit TH, Valerie K, et al. EGFRvIII-mediated radioresistance through a strong cytoprotective response. Oncogene. 2003;22(36):5545-5553."}, {"Citation": "Adamson C, Kanu OO, Mehta AI, et al. Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opin Investig Drugs. 2009;18(8):1061-1083."}, {"Citation": "Liu XJ, Wu WT, Wu WH, et al. A Minority Subpopulation of CD 133+/EGFR v III+/EGFR\u2212 Cells Acquires Stemness and Contributes to Gefitinib Resistance. CNS Neurosci Ther. 2013;19(7):494-502."}, {"Citation": "Jain R, Poisson LM, Gutman D, et al. Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor. Radiology. 2014;272(2):484-493."}, {"Citation": "Tang J, Huang N, Zhang X, et al. Aptamer-conjugated PEGylated quantum dots targeting epidermal growth factor receptor variant III for fluorescence imaging of glioma. Int J Nanomedicine. 2017;12:3899-3911."}, {"Citation": "Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977."}, {"Citation": "Momen-Heravi F, Getting SJ, Moschos SA. Extracellular vesicles and their nucleic acids for biomarker discovery. Pharmacol Ther. 2018;192:170-187."}, {"Citation": "Wu M, Chen Z, Xie Q, et al. One-step quantification of salivary exosomes based on combined aptamer recognition and quantum dot signal amplification. Biosens Bioelectron. 2021;171:112733."}, {"Citation": "Zhu N, Li G, Zhou J, et al. A light-up fluorescence resonance energy transfer magnetic aptamer-sensor for ultra-sensitive lung cancer exosome detection. J Mater Chem B. 2021;9(10):2483-2493."}, {"Citation": "Litvinov SV, Bakker HA, Gourevitch MM, Velders MP, Warnaar SO. Evidence for a role of the epithelial glycoprotein 40 (Ep-CAM) in epithelial cell-cell adhesion. Cell Adhes Commun. 1994;2(5):417-428."}, {"Citation": "Schmoll H-J, Arnold D. When wishful thinking leads to a misty-eyed appraisal: the story of the adjuvant colon cancer trials with edrecolomab. J Clin Oncol Off J Am Soc Clin Oncol. 2009;27(12):1926-1929."}, {"Citation": "Harris L, Fritsche H, Mennel R, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol. 2007;25(33):5287-5312."}, {"Citation": "Bhasin S, Zhang A, Coviello A, et al. The impact of assay quality and reference ranges on clinical decision making in the diagnosis of androgen disorders. Steroids. 2008;73(13):1311-1317."}, {"Citation": "Li N, Ebright JN, Stovall GM, et al. Technical and biological issues relevant to cell typing with aptamers. J Proteome Res. 2009;8(5):2438-2448."}, {"Citation": "Kang WJ, Chae JR, Cho YL, Lee JD, Kim S. Multiplex imaging of single tumor cells using quantum-dot-conjugated aptamers. Small. 2009;5(22):2519-2522."}, {"Citation": "Ko MH, Kim S, Kang WJ, et al. In vitro derby imaging of cancer biomarkers using quantum dots. Small. 2009;5(10):1207-1212."}, {"Citation": "Kerbel R, Folkman J. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer. 2002;2(10):727-739."}, {"Citation": "Xiong J-P, Stehle T, Diefenbach B, et al. Crystal structure of the extracellular segment of integrin \u03b1V\u03b23. Science. 2001;294(5541):339-345."}, {"Citation": "Lee J, Kang HJ, Jang H, et al. Simultaneous imaging of two different cancer biomarkers using aptamer-conjugated quantum dots. Sensors. 2015;15(4):8595-8604."}, {"Citation": "Hwang JY, Kim ST, Han H-S, Kim K, Han JS. Optical aptamer probes of fluorescent imaging to rapid monitoring of circulating tumor cell. Sensors. 2016;16(11):1909."}, {"Citation": "Sun Y, Fan J, Cui L, Ke W, Zheng F, Zhao Y. Fluorometric nanoprobes for simultaneous aptamer-based detection of carcinoembryonic antigen and prostate specific antigen. Microchim Acta. 2019;186(3):1-10."}, {"Citation": "Alizadeh N, Memar MY, Moaddab SR, Kafil HS. Aptamer-assisted novel technologies for detecting bacterial pathogens. Biomed Pharmacother. 2017;93:737-745."}, {"Citation": "Ku T-H, Zhang T, Luo H, et al. Nucleic acid aptamers: an emerging tool for biotechnology and biomedical sensing. Sensors. 2015;15(7):16281-16313."}, {"Citation": "Henkel JS, Baldwin MR, Barbieri JT. Toxins from bacteria. Mol Clin Environ Ttoxicol. EXS 2010;100:1-29."}, {"Citation": "Duan N, Wu S, Yu Y, et al. A dual-color flow cytometry protocol for the simultaneous detection of Vibrio parahaemolyticus and Salmonella typhimurium using aptamer conjugated quantum dots as labels. Anal Chim Acta. 2013;804:151-158."}, {"Citation": "Gomes TA, Elias WP, Scaletsky IC, et al. Diarrheagenic Escherichia coli. Braz J Microbiol. 2016;47:3-30."}, {"Citation": "Bintsis T. Foodborne pathogens. AIMS Microbiol. 2017;3(3):529-563."}, {"Citation": "Gao R, Zhong Z, Gao X, Jia L. Graphene oxide quantum dots assisted construction of fluorescent aptasensor for rapid detection of Pseudomonas aeruginosa in food samples. J Agric Food Chem. 2018;66(41):10898-10905."}, {"Citation": "Oliveira D, Borges A, Sim\u00f5es M. Staphylococcus aureus toxins and their molecular activity in infectious diseases. Toxins. 2018;10(6):252."}, {"Citation": "Ehling-Schulz M, Lereclus D, Koehler TM. The Bacillus cereus group: Bacillus species with pathogenic potential. Microbiol Spectrum. 2019;7(3):1-60."}, {"Citation": "Shen Y, Wu T, Zhang Y, et al. Engineering of a dual-recognition ratiometric fluorescent nanosensor with a remarkably large stokes shift for accurate tracking of pathogenic bacteria at the single-cell level. Anal Chem. 2020;92(19):13396-13404."}, {"Citation": "Chauhan P. Nanodevices for the Detection of Cancer Cells. Smart Nanodevices for Point-of-Care Applications. CRC Press; 2022:169-188."}, {"Citation": "Ikanovic M, Rudzinski WE, Bruno JG, et al. Fluorescence assay based on aptamer-quantum dot binding to Bacillus thuringiensis spores. J Fluoresc. 2007;17:193-199."}, {"Citation": "Pandit C, Alajangi HK, Singh J, et al. Development of magnetic nanoparticle assisted aptamer-quantum dot based biosensor for the detection of Escherichia coli in water samples. Sci Total Environ. 2022;831:154857."}, {"Citation": "Pebdeni AB, Hosseini M, Ganjali MR. Fluorescent turn-on aptasensor of Staphylococcus aureus based on the FRET between green carbon quantum dot and gold nanoparticle. Food Anal Methods. 2020;13:2070-2079."}, {"Citation": "Ayed Z, Malhotra S, Dobhal G, Goreham RV. Aptamer Conjugated Indium Phosphide Quantum Dots with a Zinc Sulphide Shell as Photoluminescent Labels for Acinetobacter baumannii. Nanomaterials. 2021;11(12):3317."}, {"Citation": "Bruno JG, Sivils JC. Further characterization and independent validation of a DNA aptamer-quantum dot-based magnetic sandwich assay for Campylobacter. Folia Microbiol. 2017;62:485-490."}, {"Citation": "Tao X, Liao Z, Zhang Y, et al. Aptamer-quantum dots and teicoplanin-gold nanoparticles constructed FRET sensor for sensitive detection of Staphylococcus aureus. Chin Chem Lett. 2021;32(2):791-795."}, {"Citation": "Fu F, Zhang Y, Li L, et al. Intracellular pathogen detection based on dual-recognition units constructed fluorescence resonance energy transfer nanoprobe. Anal Chem. 2020;92(16):11462-11468."}, {"Citation": "Torabfam M, Kurt H, Bayaz\u0131t MK, Y\u00fcce M. Plasmonic nanometal surface energy transfer-based dual excitation biosensing of pathogens. Sensors Diagnost. 2022;1(4):765-774."}, {"Citation": "Xu L, Callaway ZT, Wang R, et al. A fluorescent aptasensor coupled with nanobead-based immunomagnetic separation for simultaneous detection of four foodborne pathogenic bacteria. Trans ASABE. 2015;58(3):891-906."}, {"Citation": "Hua R, Hao N, Lu J, et al. A sensitive Potentiometric resolved ratiometric Photoelectrochemical aptasensor for Escherichia coli detection fabricated with non-metallic nanomaterials. Biosens Bioelectron. 2018;106:57-63."}, {"Citation": "Kurt H, Y\u00fcce M, Hussain B, Budak H. Dual-excitation upconverting nanoparticle and quantum dot aptasensor for multiplexed food pathogen detection. Biosens Bioelectron. 2016;81:280-286."}, {"Citation": "Chiu T-C, Huang C-C. Aptamer-functionalized nano-biosensors. Sensors. 2009;9(12):10356-10388."}, {"Citation": "Kesharwani P, Gothwal A, Iyer AK, Jain K, Chourasia MK, Gupta U. Dendrimer nanohybrid carrier systems: an expanding horizon for targeted drug and gene delivery. Drug Discov Today. 2018;23(2):300-314."}, {"Citation": "Warsi MH, Rahman MA, Yusuf M, et al. Drug Delivery Potential of Dendrimeric Formulation. Dendrimers in Nanomedicine. CRC Press; 2021:255-275."}, {"Citation": "Azizi M, Dianat-Moghadam H, Salehi R, et al. Interactions between tumor biology and targeted nanoplatforms for imaging applications. Adv Funct Mater. 2020;30(19):1910402."}, {"Citation": "Pastor F, Berraondo P, Etxeberria I, et al. An RNA toolbox for cancer immunotherapy. Nat Rev Drug Discov. 2018;17(10):751-767."}, {"Citation": "Wojtynek NE, Mohs AM. Image-guided tumor surgery: the emerging role of nanotechnology. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020;12(4):e1624."}, {"Citation": "Pednekar PP, Jadhav KR, Kadam VJ. Aptamer-dendrimer bioconjugate: a nanotool for therapeutics, diagnosis, and imaging. Expert Opin Drug Deliv. 2012;9(10):1273-1288."}, {"Citation": "Sekhon SS, Kaur P, Kim Y-H, Sekhon SS. 2D graphene oxide-aptamer conjugate materials for cancer diagnosis. npj 2D Mater Appl. 2021;5(1):1-19."}], "ReferenceList": [], "Title": "REFERENCES"}], "History": [{"Year": "2023", "Month": "4", "Day": "21"}, {"Year": "2023", "Month": "2", "Day": "16"}, {"Year": "2023", "Month": "5", "Day": "9"}, {"Year": "2023", "Month": "5", "Day": "24", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "5", "Day": "24", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "5", "Day": "24", "Hour": "5", "Minute": "29"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37222166", "10.1002/btpr.3366"]}}], "PubmedBookArticle": []}